Trial Emulation and Real-World Evidence
Author:
Affiliation:
1. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
2. Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2777895/groenwold_2021_ic_210045_1616097608.21161.pdf
Reference7 articles.
1. The magic of randomization versus the myth of real-world evidence.;Collins;N Engl J Med,2020
2. Text-mining in electronic healthcare records can be used as efficient tool for screening and data collection in cardiovascular trials: a multicenter validation study.;van Dijk;J Clin Epidemiol,2020
3. Association of a shortened duration of adjuvant chemotherapy with overall survival among individuals with stage III colon cancer.;Boyne;JAMA Netw Open,2021
4. Using big data to emulate a target trial when a randomized trial is not available.;Hernán;Am J Epidemiol,2016
5. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial.;Cole;Am J Epidemiol,2010
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using real-world evidence to complement evidence from randomized controlled trials on oral anticoagulants for stroke prevention;PLOS Medicine;2024-08-29
2. Target Trial Emulation: Improving the Quality of Observational Studies in Inflammatory Bowel Disease Using the Principles of Randomized Trials;Inflammatory Bowel Diseases;2024-06-11
3. Emulating trial to evaluate the effectiveness of routine supportive care on mortality among cancer patients experiencing distress at the time of diagnosis;Journal of Affective Disorders;2024-06
4. Exact-matching algorithms using administrative health claims database equivalence factors for real-world data analysis based on the target trial emulation framework;Health Services and Outcomes Research Methodology;2024-02-02
5. Emulating randomised clinical trials in relapsing-remitting multiple sclerosis with non-randomised real-world evidence: an application using data from the MSBase Registry;Journal of Neurology, Neurosurgery & Psychiatry;2024-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3